Notice for tebentafusp (Adjutor Healthcare Pty Ltd)
Active ingredients
tebentafusp
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
For the for the treatment of unresectable or metastatic uveal melanoma.
Therapeutic area
Oncology